Note, content for veterinary professionals only.

Tulissin 25® injectable solution

(tulathromycin injection)

 

TULISSIN-25_hero.jpg

 


Also Offering

TULISSIN-100_500ml_Packshot_WEB.png


Available for use in cattle and swine

Logo-Tulissin-100.svg

Download Prescribing Information     Learn More

 

 

 

You’ve trusted your herd with tulathromycin.

Now you need Tulissin® 25 injectable solution

 

calendar_icon.jpg

Provides up to 9 days of lung activity to treat and control SRD1

icon-certified_2C.jpg

Can be added to judicious antibiotic use protocols

formulated_icon.jpg

Formulated for weaned pigs to allow for accurate dosing

icon-standard.svg

Highest quality standard

(produced in an FDA/EMA Approved manufacturing facility)

icon-dose.svg

One dose means you only have to handle them once

icon-chrono.svg

Goes to work in minutes2

Concentrates in the lungs1,3

Treat and control

Indicated for the treatment of Swine Respiratory Disease (SRD)

Treat

Tulissin 25® injectable solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae. Do not inject more than 4 mL per injection site. Swine intended for human consumption must not be slaughtered within 5 days from the last treatment.

Control

Tulissin 25® injectable solution is indicated for the the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed. Not for use in animals previously found to be hypersensitive to the drug.

Two concentrations for added flexibility based on weight

Swine-Brochure_pigs_sm.jpg

  • Tulissin® 25 injectable solution is formulated for weaned pigs for increased precision
  • Tulissin 25 mg/mL For swine: 1 mL/22 lb. BW

 

Swine-Brochure_pigs_lg.jpg

  • Tulissin® 100 (tulathromycin injection) is available for use in larger pigs. Note effects on swine reproduction and lactation have not been determined.
Our Companion in the Swine Business

Important Swine Safety Information

Logo-Tulissin-25.svg

  • Do not inject more than 4 mL per injection site
  • Pre-slaughter withdrawal 5 days
  • Effects on reproduction have not been determined
  • There may be trim loss at the injection site at slaughter
  • Do not use in animals known to be hypersensitive to the product
  • Not for use in use in humans, chickens or turkeys

Prescribing-Information_button.jpg

Logo-Tulissin-100.svg

  • Do not inject more than 2.5 mL per injection site
  • Pre-slaughter withdrawal 5 days
  • Effects on reproduction have not been determined
  • There may be trim loss at the injection site at slaughter
  • Do not use in animals known to be hypersensitive to the product
  • Not for use in use in humans, chickens or turkeys

Prescribing-Information_button.jpg


Need more information?
Contact form

References

  1. Waag TA, Bradford JR, Lucas MJ, et al. Duration of effectiveness of tulathromycin injectable solution in an Actinobacillus pleuropneumoniae respiratory-disease challenge model in swine. J Swine Health Prod. 2008;16(3):126–130.

  2. Villarino N, Brown SA, Martín-Jiménez T. Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective. J. Vet Pharmacol. Therap. 37, 211- 221.

  3. Benchaoui HA, Nowakowski M, Sherington J, Rowan TG, Sunderland SJ. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J. Vet Pharmacolo. Therap. 2004;27(4):203-210.)